Table 2.

Descriptive statistics of the calculated relative risk of death or metastasis occurrence associated with the presence of CD3+, CD4+, CD8+, TIA1+ and CD20+, or with the expression of CD44s, CD44v6, CD95/Fas, Fas-L, p53 and p-glycoprotein.

Markers		Mortality			Metastization
		Fisher’s Exact Test	OR	95% CI	Fisher’s Exact Test	OR	95% CI
Tumor-Infiltrating Lymphocytes	CD3	0.503	0.514	0.124–2.138	0.734	0.623	0.150–2.587
	CD4	0.028	0.256	0.081–0.806	0.177	0.433	0.152–1.232
	CD8	0.183	0.420	0.135–1.305	0.199	0.456	0.149–1.391
	TIA1	0.656	0.812	0.332–1.986	1.000	1.056	0.434–2.566
	CD20	1.000	0.995	0.417–2.377	0.385	1.529	0.649–3.604
Tumor Markers	CD44s	0.226	0.526	0.201–1.380	0.806	0.805	0.309–2.099
	CD44v6	1.000	1.190	0.346–4.093	0.756	1.391	0.386–5.015
	CD95/Fas	0.105	0.305	0.073–1.269	0.509	0.620	0.166–2.136
	Fas-L	0.386	1.602	0.681–3.768	0.289	1.624	0.693–3.806
	p53	0.163	0.405	0.133–1.236	0.271	0.500	0.173–1.447
	P-glycoprotein	0.088	2.210	0.939–5.197	0.201	1.874	0.802–4.379

Legend: Row cells with dark background represent statistically significant value and cells with light background represent statistical value close to the significance level. OR—odds ratio; CI—Confidence Interval.